학술논문

Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
Document Type
Short Communication
Source
In Journal of Global Antimicrobial Resistance March 2023 32:44-47
Subject
Language
ISSN
2213-7165